2025年2月18日
Corporate and venture capital investment in AI start-ups has proven robust in turbulent times. Companies delivering tangible value and real-world solutions continue to attract favourable funding options. How should founders balance investment decisions against company goals, long-term vision and potential exit strategies?
Large corporate investors play a pivotal role in scaling next-generation AI. Between 2019 and 2023, AI businesses with corporate investment accounted for *more than a third (35%) of all M&A deal targets in the UK, US, and Germany. Over the same period, the acquisition of corporate-backed AI ventures grew *31%, compared to 13% in AI M&A overall.
Generative AI businesses are also among the dominant targets for the largest corporate venture capital (CVC) deals. Prime examples are Microsoft's $10 billion investment in OpenAI and its participation in a $1.3 billion round for Inflection AI alongside Nvidia.
The rise in AI CVC funds and deals is not limited to tech giants. Visa launched its GenAI fund in October 2023 to finance start-ups integrating the technology into commerce and payment products. T-Mobile Ventures launched its second fund in September 2023, adding AI to its 5G-focused technology investments.
Venture capital is the driving force behind AI innovation and growth, preparing start-ups for successful exits. In 2023, *47% of all AI deal value was VC-backed, and *55% of AI businesses acquired over the last five years had VC investment.
Generative AI remains a big bet for VCs, focused on real-world applications in key verticals and financially stable companies. PitchBook reported that more than a quarter of the capital invested in health tech in Q2 of 2023 went to companies specialising in generative AI – illustrating the shift from pure tech innovation to native solutions.
Josef Fuss, Partner, Taylor Wessing
The funding environment looks good for AI companies that provide clear value and solve actual problems. But how do founders decide what investment is right for their business and when? Corporate backing, venture capital, or both? As with any strategic decision, AI founders must consider trade-offs dictated by their goals, growth strategy and exit plan.
In a dynamic landscape, early-stage companies focusing on refining their technologies can significantly benefit from the patient capital and vast resources corporate backing offers, including access to proprietary data sets, industry expertise and established routes to market.
However, as these start-ups mature and shift towards market entry and expansion, venture capitalists' agility and extensive networks become invaluable, accelerating growth and facilitating a wider range of exit strategies.
Balancing the strengths of corporate and venture capital funding at different stages of growth can offer start-ups a robust foundation for both development and commercialisation.
Josef Fuss, Partner, Taylor Wessing
Weighing your investment options
Early-stage:
Late-stage:
*PitchBook Data, Inc.; Data has not been reviewed by PitchBook analysts.